Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep:7:1010-1020.
doi: 10.1038/s41929-024-01213-5. Epub 2024 Sep 9.

Enantioselective Chan-Lam S-Arylation of Sulfenamides

Affiliations

Enantioselective Chan-Lam S-Arylation of Sulfenamides

Qingjin Liang et al. Nat Catal. 2024 Sep.

Abstract

Sulfur-stereogenic molecules have a significant impact on drug development, but are underexplored largely due to our limited ability to construct such structures. Among them, sulfilimines are a class of chiral molecules bearing S(IV)-stereocenters, which exhibit great value in chemistry and biology but were synthetically intractable previously. We report a highly chemoselective and enantioselective Chan-Lam S-arylation of sulfenamides with arylboronic acids to deliver an array of thermodynamically disfavored diaryl and alkyl aryl sulfilimines containing a sulfur stereocenter. Though Chan-Lam coupling has been widely used to construct C-N, C-O and C-S bonds by coupling nucleophiles with boronic acids using copper complexes in academia and industry, control of the stereochemistry in this textbook transformation has proven to be a formidable challenge. A new copper catalyst from a 2-pyridyl N-phenyl dihydroimidazole ligand has been designed that enables effective enantiocontrol by means of a well-defined chiral environment and high reactivity that outcompetes the background racemic transformation. A combined experimental and computational study establishes the reaction mechanism and unveils the origin of chemoselectivity and stereoselectivity.

PubMed Disclaimer

Conflict of interest statement

Competing interests The authors declare no competing interests.

Figures

Figure 1
Figure 1
a) Formation of common intermediate 2a’, which can undergo N-arylation or S-arylation. b) Formation of S-arylation product 3-S via kinetic control. c) Formation of (S)-product over (R)-product, an entropically controlled process. All free energies were computed using UM06/6–311++G(d,p)-SDD(Cu)-CPCM(DME)//UB3LYP-D3/6–31G(d)-SDD(Cu).
Scheme 1.
Scheme 1.
Background and Conceptual Design
Scheme 2.
Scheme 2.
Synthetic Applications

References

    1. Lücking U Sulfoximines: A Neglected Opportunity in Medicinal Chemistry. Angew. Chem. Int. Ed 52, 9399–9408 (2013).
    1. Lücking U New Opportunities for the Utilization of the Sulfoximine Group in Medicinal Chemistry from the Drug Designer’s Perspective. Chem. Eur. J 28, e202201993 (2022). - PubMed
    1. Kaiser D, Klose I, Oost R, Neuhaus J & Maulide N Bond-Forming and -Breaking Reactions at Sulfur(IV): Sulfoxides, Sulfonium Salts, Sulfur Ylides, and Sulfinate Salts. Chem. Rev 119, 8701–8780 (2019). - PMC - PubMed
    1. Wojaczynska E & Wojaczynski J Modern Stereoselective Synthesis of Chiral Sulfinyl Compounds. Chem. Rev 120, 4578–4611 (2020). - PMC - PubMed
    1. Gilchrist TL & Moody CJ The Chemistry of Sulfilimines. Chem. Rev 77, 409–435 (1977).

LinkOut - more resources